Neith Corporation (TPEX:6236)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Information Department	55.02M	56.57M	19.32M	4.12M	-
Information Department Growth	-2.75%	192.88%	368.38%	-	-
Adjustments and Eliminations	-19.76M	-13.99M	-	-40.00K	-
Biotech Medical Sector	883.00K	2.99M	17.36M	27.84M	31.05M
Biotech Medical Sector Growth	-70.50%	-82.76%	-37.65%	-10.34%	-28.38%
Other	-	-	3.23M	133.00K	337.00K
Other Growth	-	-	2327.82%	-60.53%	-12.92%
Total	36.15M	45.57M	39.90M	32.06M	31.39M
Total Growth	-20.68%	14.20%	24.48%	2.13%	-28.24%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Taiwan	34.66M	44.04M	39.90M	31.94M	31.39M
Taiwan Growth	-21.30%	10.38%	24.92%	1.76%	-28.17%
Other Countries	1.48M	1.53M	-	114.00K	-
Other Countries Growth	-3.01%	-	-	-	-
Total	36.15M	45.57M	39.90M	32.06M	31.39M
Total Growth	-20.68%	14.20%	24.48%	2.13%	-28.24%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 10, 2026

Data Sources Report a data error